Depressive Disorder, Treatment-Resistant

One-Day cTBS Over the Precuneus

Dopaminergic Dysfunction in Late-Life Depression

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

Improving Brain Stimulation Through Imaging

A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant Depression

A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With Treatment-resistant Depression

Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits

rTMS With and Without Text4Support for the Treatment of Resistant Depression.

Adaptive tDCS for Treatment-Resistant MDD

Accelerated vs. Conventional Theta Burst Stimulation for Late-life Depression

NESBID: Neuro-Stimulation of the Brain in Depression

Effects of a Classic High-frequency rTMS Treatment Versus a Deep rTMS Treatment

Intravenous Ketamine for Treatment-Resistant Depression

Behavioural Activation Therapy and Esketamine for Resistant Depression

Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression

Pre-Approval Access to Esketamine Nasal Spray for the Treatment of Treatment-Resistant Depression (TRD)

Investigate the Clinical Responses of Ethosuximide in Patients With Treatment-Resistant Depression.

A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression